Of note, the same group successfully used tumor antigen-specific RNA-LPXs to trigger endogenous CD4 and CD8 T cell-mediated destruction of antigen-presenting tumor cells in mice and patients [46,47]. The gene discussed is CD8A; the disease is neoplasm.